Holen Sie sich die Stockscreener-App
7.17
6.88%
-0.53
Schlusskurs vom Vortag:
$7.70
Offen:
$7.51
24-Stunden-Volumen:
7,464
Relative Volume:
0.16
Marktkapitalisierung:
$4.12M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-17.06M
KGV:
-0.1014
EPS:
-70.7173
Netto-Cashflow:
$-14.18M
1W Leistung:
-14.13%
1M Leistung:
-19.93%
6M Leistung:
-47.12%
1J Leistung:
-89.39%
1-Tages-Spanne:
$7.16
$7.52
1-Wochen-Bereich:
$7.16
$8.65
52-Wochen-Spanne:
$4.93
$114.00
Cns Pharmaceuticals Inc Stock (CNSP) Company Profile
Firmenname
Cns Pharmaceuticals Inc
Sektor
Branche
Telefon
1-800-946-9185
Adresse
2100 WEST LOOP SOUTH, HOUSTON
Vergleichen Sie CNSP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNSP
Cns Pharmaceuticals Inc
|
7.17 | 4.42M | 0 | -17.06M | -14.18M | -70.72 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cns Pharmaceuticals Inc Stock (CNSP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2020-08-24 | Eingeleitet | Ladenburg Thalmann | Buy |
Cns Pharmaceuticals Inc Aktie (CNSP) Neueste Nachrichten
Will CNS Pharmaceuticals Inc. stock deliver better than expected guidanceJuly 2025 Reactions & Fast Exit/Entry Strategy Plans - newser.com
Will CNS Pharmaceuticals Inc. stock gain from government policiesPortfolio Risk Report & Weekly High Potential Stock Alerts - newser.com
Full technical analysis of CNS Pharmaceuticals Inc. stock2025 Support & Resistance & Intraday High Probability Setup Alerts - newser.com
Is CNS Pharmaceuticals Inc. stock dividend yield sustainableQuarterly Growth Report & Accurate Intraday Trading Signals - newser.com
Can CNS Pharmaceuticals Inc. hit a new high this monthWeekly Trade Summary & Detailed Earnings Play Strategies - newser.com
Why CNS Pharmaceuticals Inc. stock remains resilientWatch List & Growth Focused Entry Point Reports - newser.com
Using Ichimoku Cloud for CNS Pharmaceuticals Inc. technicalsTrade Volume Report & Risk Controlled Daily Plans - newser.com
Can volume confirm reversal in CNS Pharmaceuticals Inc.July 2025 Movers & Safe Capital Growth Trade Ideas - newser.com
Will CNS Pharmaceuticals Inc. stock return to pre crisis levelsGap Up & Free Technical Confirmation Trade Alerts - newser.com
Custom watchlist performance reports with CNS Pharmaceuticals Inc.Quarterly Earnings Report & Risk Managed Investment Strategies - newser.com
Will CNS Pharmaceuticals Inc. stock recover faster than peersWeekly Trade Recap & Reliable Breakout Stock Forecasts - newser.com
Is CNS Pharmaceuticals Inc. stock reversal real or fakeQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
Will CNS Pharmaceuticals Inc. stock outperform value stocksJuly 2025 Volume & Risk Managed Investment Signals - newser.com
Trend analysis for CNS Pharmaceuticals Inc. this weekOptions Play & Community Driven Trade Alerts - newser.com
Will CNS Pharmaceuticals Inc. stock recover after recent drop2025 Dividend Review & Accurate Buy Signal Alerts - newser.com
Finanzdaten der Cns Pharmaceuticals Inc-Aktie (CNSP)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):